Desogestrel
Cerazette is used to prevent pregnancy. The tablets contain a small amount of the female sex hormone, progestogen, called desogestrel. For this reason, Cerazette is called a progestogen-only pill. Unlike combined contraceptive pills, progestogen-only pills do not contain estrogen, the other female sex hormone.
The mechanism of action of most progestogen-only pills is mainly based on preventing sperm from migrating through the cervix. Unlike combined contraceptive pills, they do not always inhibit the maturation of the egg cell. Cerazette differs from other progestogen-only pills in that, like combined pills, it usually inhibits the maturation of the egg cell. As a result, Cerazette is a very effective contraceptive.
Unlike combined products, it can be used by women who are intolerant to estrogens and by breastfeeding women. The biggest inconvenience when using Cerazette may be irregular bleeding. Bleeding may also not occur at all.
The possibility of becoming pregnant while using Cerazette (provided that no tablet is missed) is very low.
Cerazette, like other hormonal contraceptives, does not protect against HIV (AIDS) and other sexually transmitted diseases.
Cerazette should not be used in the case of any of the following conditions. If any of these conditions occur, you should inform your doctor before starting to use Cerazette. The doctor may advise the use of a non-hormonal contraceptive method.
If any of the above conditions occur for the first time while using Cerazette, you should immediately consult a doctor.
When using Cerazette in any of the following situations, close medical supervision is required. Before starting to use Cerazette, you should inform your doctor about:
Reduced bone mass
Estrogens play an important role in maintaining normal bone mass. During the use of Cerazette, the level of natural estrogen - estradiol in the blood is comparable to its level in the first half of the natural cycle of a woman, but reduced compared to its level in the second half of the natural cycle. It is not known whether this has an effect on bone mass.
Breast cancer
Every woman is exposed to the risk of breast cancer, regardless of whether she uses contraceptive pills or not. In women using contraceptive pills, breast cancer occurs slightly more often than in women of the same age who do not use them. After stopping the use of contraceptive pills, the risk decreases gradually and after 10 years of stopping the use of contraceptive pills, it is the same for women who used contraceptive pills and those who never used them. Breast cancer occurs less often in women under 40, but the risk increases with the age of the woman. Therefore, more cases of breast cancer occur in women using contraceptive pills at an older age. The duration of use of contraceptive pills is not as important.
Out of every 10,000 women using contraceptive pills for no more than 5 years, up to the age of 20, fewer than 1 additional case of breast cancer was diagnosed within 10 years of stopping the use of contraceptive pills, compared to 4 cases of breast cancer usually diagnosed in this age group. Similarly, out of every 10,000 women using contraceptive pills for up to 5 years, up to the age of 30, 5 additional cases of breast cancer were diagnosed, compared to 44 cases usually diagnosed in this age group. Out of every 10,000 women using contraceptive pills for up to 5 years, over the age of 40, 20 more cases of breast cancer were diagnosed, compared to 160 cases usually diagnosed.
The risk of breast cancer in women using progestogen-only pills, such as Cerazette, is similar to the risk of breast cancer in women using combined pills, but the evidence is not final.
Cases of breast cancer diagnosed in patients using contraceptive pills seem to be less advanced than those found in women who do not use them. It is not known whether this difference is related to the use of contraceptive pills. It may be related to more frequent medical check-ups and thus earlier detection of breast cancer.
Venous thromboembolic disease
Venous thromboembolic disease is the formation of a blood clot that can block a blood vessel. Sometimes it can occur in the deep veins of the legs (deep vein thrombosis). If the clot breaks loose from the place where it was formed, it can reach the lungs and block a pulmonary artery, forming a pulmonary embolism. This can lead to death. Deep vein thrombosis is very rare. It can also develop if you do not use contraceptive pills. It can also occur during pregnancy. The risk of venous thromboembolic disease is higher in women using contraceptive pills than in those who do not use them.
It is assumed that the risk of venous thromboembolic disease in women using progestogen-only pills, such as Cerazette, is lower than in women using combined contraceptive pills that also contain estrogen in their composition. If symptoms of venous thromboembolic disease occur, you should immediately contact a doctor (see "Regular check-ups").
Psychiatric disorders
Some women using hormonal contraceptives, including Cerazette, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts. If mood changes and symptoms of depression occur, you should contact a doctor as soon as possible to receive further medical advice.
There are no clinical data available on the efficacy and safety of Cerazette in adolescents under 18 years of age.
You should inform your doctor about the medicines or herbal products you are currently using or have recently used, as well as those you plan to use. You should also inform your doctor or dentist about the use of Cerazette. They may inform you about the need to use additional contraceptive methods (e.g. condoms) and the duration of their use, as well as whether it is necessary to modify the use of the prescribed medicine.
Certain medicines:
This applies to medicines used to treat:
If you are taking medicines or herbal products that may reduce the effectiveness of Cerazette, you should also use a mechanical contraceptive method. Due to the fact that the effect of another medicine on Cerazette may persist for up to 28 days after stopping the use of the medicine, it is necessary to use additional mechanical contraception during this time. Your doctor will inform you about the need to use additional contraceptive methods and the duration of their use.
Cerazette may also interfere with the action of other medicines, causing an increase (e.g. medicines containing cyclosporin) or decrease (e.g. lamotrigine) in their effect.
Before taking any medicine, you should consult a doctor or pharmacist.
During the use of Cerazette, vaginal bleeding may occur irregularly. This may be slight spotting or intense bleeding. Bleeding may also not occur.
Irrregular bleeding does not mean that the contraceptive effectiveness of Cerazette is reduced. Usually, no action is required, and you should continue to take Cerazette. However, if the bleeding is very heavy or prolonged, you should contact a doctor.
During the use of all contraceptive methods containing small amounts of hormones, small fluid-filled blisters called functional ovarian cysts may develop in the ovaries. They usually disappear on their own. In some cases, they may cause slight abdominal pain. Rarely, they may require surgical intervention.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult a doctor or pharmacist before using this medicine.
Pregnancy
Using Cerazette is contraindicated in pregnancy or if pregnancy is suspected.
Breastfeeding
Cerazette can be used during breastfeeding. It does not seem to affect milk production or the quality of the milk secreted. However, a decrease in milk production has occasionally been reported during the use of Cerazette. Small amounts of the active substance of Cerazette pass into breast milk.
There are observations of the health of children up to 2.5 years of age whose mothers used Cerazette for 7 months. No effect on the growth and development of the child has been observed. If you are breastfeeding and want to use Cerazette, you should contact a doctor.
It has not been found that Cerazette affects the ability to drive and use machines.
Cerazette contains lactose. If you have previously been diagnosed with intolerance to some sugars, you should contact a doctor before taking the medicine.
A woman using Cerazette should be informed by her doctor about the need for regular check-ups. Usually, the frequency and type of check-ups depend on the individual characteristics of the woman.
You should contact a doctor immediately in the following situations:
This medicine should always be used as directed by your doctor. If you are unsure, you should consult a doctor or pharmacist.
The Cerazette blister pack contains 28 tablets. On one side of the blister pack, each tablet has a symbol of the day of the week on which it should be taken, and on the other side, there are arrows indicating the direction of the tablets to be taken. Each time you start taking tablets from a new Cerazette blister pack, you should start with the tablet marked with the corresponding day of the week. Take one tablet a day, following the direction of the arrows, until the blister pack is empty, e.g. if you start taking the tablets on a Wednesday, take the tablet marked with the symbol "Mi" (meaning Wednesday; see "Translation of the day of the week symbols on the packaging" at the end of the leaflet and on the blister pack). This will help you easily check if the tablet marked with a given day of the week symbol has been taken on that day. Take the tablets at the same time every day. Swallow the tablet whole with water. During the use of Cerazette, slight bleeding may occur. In this case, however, you should continue to take the tablets. After finishing the tablets in the blister pack, start taking the tablets from a new blister pack the next day, without interruption and without waiting for bleeding to occur.
Taking Cerazette tablets can be stopped at any time. If you do not plan to become pregnant, you should ask your doctor for another contraceptive method.
If you plan to become pregnant, it is usually recommended to wait until the first natural menstrual period before becoming pregnant. This will make it easier to determine the expected date of delivery.
No serious, harmful effects have been observed after taking more than one Cerazette tablet at the same time. Nausea, vomiting, and slight vaginal bleeding may occur in both women and young girls. You should consult a doctor.
If the delay in taking a tablet is less than 12 hours, the effectiveness of the tablet is maintained. You should take the missed tablet as soon as possible, and take the remaining tablets as usual.
If the delay in taking a tablet is more than 12 hours, the effectiveness of the tablet may be reduced. The more missed tablets, the higher the risk of reduced contraceptive effectiveness. You should take the missed tablet as soon as possible, and take the remaining tablets as usual. For the next 7 days, you should use an additional contraceptive method (e.g. a condom). There is a possibility of becoming pregnant if you miss one or more tablets in the first week of taking the tablets, if you had sex in the week before missing the tablet. You should consult a doctor.
You should follow the same procedure as when missing a tablet (see above). If vomiting or severe diarrhea occur within 3 to 4 hours of taking a Cerazette tablet, the absorption of the active substance may have been reduced. In the case of severe diarrhea, you should contact a doctor.
You can stop taking Cerazette at any time. If you do not plan to become pregnant, you should ask your doctor for another contraceptive method.
If you plan to become pregnant, it is usually recommended to wait until the first natural menstrual period before becoming pregnant. This will make it easier to determine the expected date of delivery.
Like all medicines, Cerazette can cause side effects, although not everybody gets them.
You should inform your doctor about any unwanted changes in your health, especially if they are severe and prolonged, and about changes in your health that seem to be caused by taking Cerazette tablets.
Severe side effects related to the use of Cerazette are described in the "Breast cancer" and "Venous thromboembolic disease" sections in point 2 "Important information before using Cerazette". You should read this section to obtain additional information and, if necessary, immediately consult a doctor.
If allergic reactions occur (hypersensitivity), including swelling of the face, lips, tongue, and/or throat causing difficulty breathing or swallowing (angioedema and/or anaphylactic reaction), you should immediately contact a doctor.
During the use of Cerazette, vaginal bleeding may occur irregularly. This may be slight spotting or more intense bleeding, which looks more like a scarce menstrual bleeding, when it is necessary to use sanitary pads. Bleeding may also not occur. Irregular bleeding does not mean that the contraceptive effectiveness of Cerazette is reduced. Usually, no action is required, and you can continue to take Cerazette. However, if the bleeding is very heavy or prolonged, you should contact a doctor.
Women using Cerazette have reported the following side effects:
Common: may occur in up to 1 in 10 women
Uncommon: may occur in up to 1 in 100 women
Rare: may occur in up to 1 in 1,000 women
Frequency not known (frequency cannot be estimated from the available data)
Besides the above-mentioned side effects, breast discharge may also occur.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of this medicine.
The medicine should be stored out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special storage instructions for the temperature. Store the blister pack in the original sachet to protect it from light and moisture. After opening the sachet, the product should be used within 1 month.
The active substance shows a risk to the environment in relation to fish.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The tablets are white, round, biconvex, 5 mm in diameter, marked with the code 2 below KV on one side and the inscription Organon and a star on the other.
A PVC/Aluminium blister pack containing 28 tablets is packaged in a separate sachet made of laminated aluminum foil. 1 or 3 blister packs in a cardboard box.
A cardboard sachet is included in the packaging, in which you should place the blister pack after removing it from the protective foil.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Organon Biosciences S.R.L.
Av. Popișteanu, No. 54A
Expo Business Park
Building 2, Office 306 and Office 307
Floor 3, Sector 1, Bucharest
Romania
N.V. Organon
Kloosterstraat 6
5349 AB Oss
Netherlands
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Marketing authorization number in Romania, the country of export: 10970/2018/01
10970/2018/02
10970/2018/03
Parallel import authorization number: 77/20
Lu
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.